NCT02797769 A Time to Cardiovascular Event Analysis Comparing Tocilizumab to Other Biologics in Patients With Rheumatoid Arthritis (RA) Status COMPLETED Phase N/A
NCT02778789 Comparing the Efficacy of Periarticular Bone Structure in Patients Treated With Either Tocilizumab or Tumor Necrosis Factor Blockers Status COMPLETED Phase N/A
NCT02767557 Study of Nab-Paclitaxel and Gemcitabine With or Without Tocilizumab in Pancreatic Cancer Patients Status COMPLETED Phase PHASE2
NCT02735707 Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia Status RECRUITING Phase PHASE3
NCT02721004 Efficacy and Safety Study of RoActemra (Tocilizumab) in Participants With Rheumatoid Arthritis Status COMPLETED Phase N/A
NCT02682823 Tocilizumab Real-Life Human Factors (RLHFs) Validation Study Status COMPLETED Phase PHASE4
NCT02678988 A Study to Evaluate the Bioequivalence of Tocilizumab Following Subcutaneous Administration Via an Autoinjector (AI 1000-G2) Versus a Pre-Filled Syringe in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT02676947 A Therapeutic Open Label Study of Tocilizumab in the Treatment of Pulmonary Arterial Hypertension Status COMPLETED Phase PHASE2
NCT02660528 Tocilizumab Augmentation in Treatment-Refractory Major Depressive Disorder Status TERMINATED Phase PHASE2
NCT02659150 Effect of Subcutaneous ACTEMRA on Inflamed Atherosclerotic Plaques in Patients With Rheumatoid Arthritis Status TERMINATED Phase PHASE4
NCT02648035 EMBRACE-SC: Observational Study of Subcutaneous (SC) Tocilizumab Alone or in Combination With Conventional Disease-Modifying Antirheumatic Drugs (cDMARDs) in Rheumatoid Arthritis Status COMPLETED Phase N/A
NCT02608112 Study to Describe Real World Drug Retention Rate of the Tocilizumab at One Year Status COMPLETED Phase N/A
NCT02573012 Study to Compare the Efficacy of Tocilizumab With or Without Glucocorticoid Discontinuation in Rheumatoid Arthritis Participants Status COMPLETED Phase PHASE4
NCT02552940 An Observational Study to Evaluate the Clinical Effectiveness, Quality of Life, Safety and Tolerability of Tocilizumab (TCZ) in Patients With Rheumatoid Arthritis (RA) in Daily Clinical Practice Status COMPLETED Phase N/A
NCT02534311 A Phase IV Study to Evaluate the Effect of Subcutaneous (SC) Tocilizumab Administered to Participants With Rheumatoid Arthritis (RA) Assessed Using Disease Activity Score (DAS28) Status COMPLETED Phase N/A
NCT02511067 Ranibizumab for Edema of the mAcula in Diabetes: Protocol 4 With Tocilizumab: The READ-4 Study Status WITHDRAWN Phase PHASE2
NCT02477059 Effect of the Interleukin-6 Receptor Antagonist Tocilizumab in Patients With Hand Osteoarthritis Status COMPLETED Phase PHASE3
NCT02453256 A Study of the Efficacy and Safety of Tocilizumab in Participants With Systemic Sclerosis (SSc) Status COMPLETED Phase PHASE3
NCT02447055 Allogeneic Stem Cell Transplantation for Patients With Multiple Myeloma Status WITHDRAWN Phase EARLY_PHASE1